Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst James Quigley initiated coverage on Sanofi (NASDAQ:SNY) with a Neutral rating and announced a price target of $65. Sanofi shares closed at $57.79 on Thursday. See how other analysts view this stock.
- Raymond James analyst Daniel Tamayo initiated …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst James Quigley initiated coverage on Sanofi (NASDAQ:SNY) with a Neutral rating and announced a price target of $65. Sanofi shares closed at $57.79 on Thursday. See how other analysts view this stock.
- Raymond James analyst Daniel Tamayo initiated …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Goldman Sachs analyst James Quigley initiated coverage on Sanofi (NASDAQ:SNY) with a Neutral rating and announced a price target of $65. Sanofi shares closed at $57.79 on Thursday. See how other analysts view this stock.
Raymond James analyst Daniel Tamayo initiated …Full story available on Benzinga.com Read MoreACNB, ANIX, News, SNY, Top Initiations, UAMY, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, SNY, US80105N1054, UAMY, ACNB, ANIX, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
